Related Experiment Video
Updated: Apr 25, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
14.9K
Endocrine function over time in patients with myotonic dystrophy type 1.
J R Dahlqvist1, M C Ørngreen, N Witting
1Neuromuscular Research Unit, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
European Journal of Neurology
|August 27, 2014
Summary
Endocrine dysfunction significantly increases over time in patients with myotonic dystrophy type 1 (DM1). Regular monitoring for correctable hormonal abnormalities is recommended for this patient group.
Area of Science:
- Endocrinology
- Genetics
- Neurology
Background:
- Myotonic dystrophy type 1 (DM1) is associated with a higher prevalence of endocrine dysfunction.
- Understanding the progression of endocrine issues in DM1 patients is crucial for management.
Purpose of the Study:
- To investigate the temporal evolution of endocrine dysfunction in patients diagnosed with myotonic dystrophy type 1.
- To assess the long-term changes in hormonal balance and metabolic function in DM1 patients.
Main Methods:
- Longitudinal study of 68 DM1 patients over an average of 8 years.
- Hormone and metabolite blood level measurements.
- Libido assessment using validated questionnaires.
Main Results:
- Endocrine dysfunction increased from 30 to 57 out of 68 patients over 8 years.
- Diabetes cases rose from 1 to 4.
- Hyperparathyroidism increased to 25%, abnormal TSH to 21%, and elevated LH in men to 16/33.
Conclusions:
- Endocrine abnormalities progressively worsen in DM1 patients over time.
- Periodic screening for and management of correctable endocrine issues are advised for DM1 patients.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
01:11Alterations in Muscle Tone lll
25
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
25
01:12Alterations in Muscle Tone ll
25
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
25
01:27Major Hormones and Their Functions
3.6K
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
3.6K
01:15Myasthenia Gravis: Diagnostic Tests
3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
01:20Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K